...
首页> 外文期刊>PLoS One >E4 Antibodies Facilitate Detection and Type-Assignment of Active HPV Infection in Cervical Disease
【24h】

E4 Antibodies Facilitate Detection and Type-Assignment of Active HPV Infection in Cervical Disease

机译:E4抗体有助于宫颈疾病中主动HPV感染的检测和类型分配

获取原文
   

获取外文期刊封面封底 >>

       

摘要

High-risk human papillomavirus (HPV) infections are the cause of nearly all cases of cervical cancer. Although the detection of HPV DNA has proved useful in cervical diagnosis, it does not necessarily predict disease presence or severity, and cannot conclusively identify the causative type when multiple HPVs are present. Such limitations may be addressed using complementary approaches such as cytology, laser capture microscopy, and/or the use of infection biomarkers. One such infection biomarker is the HPV E4 protein, which is expressed at high level in cells that are supporting (or have supported) viral genome amplification. Its distribution in lesions has suggested a role in disease staging. Here we have examined whether type-specific E4 antibodies may also allow the identification and/or confirmation of causal HPV-type. To do this, type-specific polyclonal and monoclonal antibodies against three E4 proteins (HPV-16, -18, and -58) were generated and validated by ELISA and western blotting, and by immunohistochemistry (IHC) staining of epithelial rafts containing these individual HPV types. Type-specific detection of HPV and its associated disease was subsequently examined using formalin-fixed paraffin-embedded cervical intra-epithelial neoplasias (CIN, (n = 247)) and normal controls (n = 28). All koilocytotic CIN1 lesions showed type-specific E4 expression of their respective HPV types. Differences were noted amongst E4 expression patterns in CIN3. HPV-18 E4 was not detected in any of the 6 HPV-18 DNA-positive CIN3 lesions examined, whereas in HPV-16 and -58 CIN3, 28/37 (76%) and 5/9 (55.6%) expressed E4 respectively, usually in regions of epithelial differentiation. Our results demonstrate that type-specific E4 antibodies can be used to help establish causality, as may be required when multiple HPV types are detected. The unique characteristics of the E4 biomarker suggest a role in diagnosis and patient management particularly when used in combination.
机译:高危型人乳头瘤病毒(HPV)感染是几乎所有子宫颈癌病例的原因。尽管已证明对HPV DNA的检测可用于宫颈诊断,但它不一定能预测疾病的存在或严重程度,并且在存在多个HPV时不能最终确定病因类型。可以使用诸如细胞学,激光捕获显微镜和/或使用感染生物标记物等补充方法来解决此类局限性。一种这样的感染生物标志物是HPV E4蛋白,其在支持(或已经支持)病毒基因组扩增的细胞中高水平表达。其在病变中的分布表明在疾病分期中起作用。在这里,我们检查了类型特异性E4抗体是否也可以识别和/或确认因果HPV型。为此,生成了针对三种E4蛋白(HPV-16,-18和-58)的类型特异性多克隆抗体和单克隆抗体,并通过ELISA和Western印迹以及包含这些抗体的上皮筏的免疫组织化学(IHC)染色进行了验证HPV类型。随后使用福尔马林固定石蜡包埋的宫颈上皮内瘤样变(CIN,n = 247)和正常对照组(n = 28)检查HPV及其相关疾病的类型特异性检测。所有胆小细胞性CIN1病变均显示其各自HPV类型的类型特异性E4表达。注意到在CIN3中E4表达模式之间存在差异。在检查的6个HPV-18 DNA阳性CIN3病变中均未检测到HPV-18 E4,而在HPV-16和-58 CIN3中,分别表达28/37(76%)和5/9(55.6%)的E4。 ,通常在上皮细胞分化的区域。我们的结果表明,检测到多种HPV类型时可能需要使用类型特异性E4抗体来帮助建立因果关系。 E4生物标志物的独特特征提示了其在诊断和患者管理中的作用,尤其是在组合使用时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号